Enphase Energy To Rally Over 35%? Here Are 10 Top Analyst Forecasts For Tuesday
Portfolio Pulse from Avi Kapoor
Several top Wall Street analysts have updated their price targets and ratings for various US-listed companies. Notably, Truist Securities raised the price target for Enphase Energy, Inc. (ENPH) from $85 to $145 and upgraded the stock to Buy, implying over a 35% potential rally. Other companies such as Constellium SE (CSTM), Zuora, Inc. (ZUO), Teva Pharmaceutical (TEVA), NuStar Energy L.P. (NS), Callon Petroleum Company (CPE), BioNTech SE (BNTX), Viant Technology Inc. (DSP), Chevron Corporation (CVX), and Materion Corporation (MTRN) also saw changes in their price targets and ratings.
January 23, 2024 | 12:44 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Deutsche Bank raised Constellium's price target from $21 to $24 and maintained a Buy rating.
The price target increase and continued Buy rating by Deutsche Bank may positively influence CSTM's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Needham raised Viant Technology's price target from $7.5 to $10 and maintained a Buy rating.
The increased price target and sustained Buy rating by Needham could lead to a positive short-term impact on DSP's stock price.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Truist Securities upgraded Enphase Energy to Buy and raised the price target from $85 to $145, indicating a significant potential upside.
The substantial increase in the price target and upgrade to Buy by Truist Securities could lead to increased investor confidence and a potential short-term rally in ENPH's stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Keybanc raised Materion's price target from $130 to $140 and maintained an Overweight rating.
The price target increase and continued Overweight rating by Keybanc may have a positive short-term impact on MTRN's stock price.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Wells Fargo upgraded NuStar Energy from Underweight to Equal-Weight and raised the price target from $18 to $21.
The upgrade to Equal-Weight and the price target increase by Wells Fargo are likely to have a positive short-term impact on NS's stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Jefferies upgraded Teva Pharmaceutical from Hold to Buy and raised the price target from $10 to $14.
The upgrade and increased price target for Teva Pharmaceutical by Jefferies could positively affect the stock's short-term performance.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Goldman Sachs upgraded Zuora from Neutral to Buy and increased the price target from $10 to $12.
The upgrade to Buy and higher price target from Goldman Sachs could lead to a positive short-term impact on ZUO's stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
HC Wainwright & Co. cut BioNTech's price target from $133 to $107 but maintained a Buy rating.
While the price target was reduced, the maintenance of a Buy rating by HC Wainwright & Co. could have a neutral to slightly positive impact on BNTX's stock price.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Stifel downgraded Callon Petroleum from Buy to Hold and cut the price target from $44 to $32.
The downgrade to Hold and reduced price target by Stifel could negatively influence CPE's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
TD Cowen downgraded Chevron from Outperform to Market Perform and cut the price target from $170 to $150.
The downgrade to Market Perform and lower price target by TD Cowen could have a negative short-term impact on CVX's stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80